Clinical Trial Update: Pharmacogenetics and Model-Informed Optimisation of Hydroxyurea

View source ↗

Summary

Clinical trial exploring pharmacogenetics and model-informed optimization of hydroxyurea for sickle cell disease; status indicates not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Ochuko Orherhe | Conditions: Sickle Cell Disease | Status: NOT_YET_RECRUITING